FEDELE, CARMINE
 Distribuzione geografica
Continente #
NA - Nord America 242
EU - Europa 96
AS - Asia 49
AF - Africa 5
Totale 392
Nazione #
US - Stati Uniti d'America 235
IT - Italia 28
SE - Svezia 27
CN - Cina 24
SG - Singapore 21
IE - Irlanda 12
FI - Finlandia 9
CA - Canada 7
DE - Germania 6
GB - Regno Unito 6
NL - Olanda 6
CI - Costa d'Avorio 5
IN - India 3
CH - Svizzera 1
ES - Italia 1
KR - Corea 1
Totale 392
Città #
Chandler 50
Ashburn 25
Singapore 15
Millbury 9
Naples 9
Princeton 9
Boardman 7
Ottawa 7
Amsterdam 6
Boston 6
Jacksonville 6
Nanchang 6
Washington 6
Falls Church 5
Kronberg 5
Beijing 4
Kunming 4
Santa Clara 4
Wilmington 4
Houston 3
Los Angeles 3
Ann Arbor 2
Dallas 2
Jiaxing 2
Nanjing 2
Napoli 2
Norwalk 2
Portici 2
Riva Del Garda 2
Winthrop 2
Cerdanyola del Vallès 1
Changchun 1
Hangzhou 1
Hebei 1
Kwangju 1
London 1
Miami 1
Munich 1
New York 1
Pozzuoli 1
Pune 1
San Giuseppe Vesuviano 1
Seattle 1
Shanghai 1
Yellow Springs 1
Zhengzhou 1
Zurich 1
Totale 228
Nome #
A novel fully human Antitumor ImmunoRNase targeting ErbB2-positive tumors 61
A novel ErbB2 epitope targeted by Human antitumor Immunoagents 58
Esiste la possibilità di ipotizzare un blocco dei recettori HER con immunoagenti senza effetti cardiotossici? 48
Novel Human Anti-ErbB2 Immunoagents 47
Novel Human Anti-ErbB2 Immunoagents 38
Effects of a human compact anti-ErbB2 antibody on prostate cancer 38
Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors. 35
Mechanisms of cardiotoxicity associated with ErbB2 inhibitors. 34
Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents 28
A novel ErbB2 epitope targeted by human antitumor immunoagents 10
Totale 397
Categoria #
all - tutte 1.845
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.845


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 2 0 0 0 0 2 5 4
2020/202141 5 0 9 3 3 12 0 0 3 3 3 0
2021/202279 3 0 1 0 1 6 0 7 15 1 25 20
2022/202399 9 7 6 13 13 15 0 8 14 6 6 2
2023/202488 2 12 12 13 11 15 0 11 0 3 7 2
2024/202530 10 8 1 2 9 0 0 0 0 0 0 0
Totale 397